期刊文献+

支气管肺泡灌洗液肿瘤标志物联合检测诊断肺癌的研究 被引量:9

DIAGNOSIS OF LUNG CANCER BY COMBINED TUMOR MARKERS IN BLONCHOALVEOLAR LAVAGE FLUIDS
下载PDF
导出
摘要 探讨支气管肺泡灌洗液中的成分对肺癌的诊断价值。方法:应用纤维支气管镜行支气管肺泡灌洗,收集其灌洗液检测 C E A 、β2 - M G,并选择钾离子( K+ ) 作校正后进行统计学处理分析。结果:肺癌组 B A L F 测得 C E A/ K+ 与β2 - M G/ K+ 数值经统计学处理均分别较良性肺病组增高,两组阳性率比较均具有显著意义,若同时测定 C E A/ K+ 、β2 - M G/ K+ 加上癌细胞学三项联合检测,就有93 .75 % 的癌症患者至少有一项或以上的指标阳性,诊断准确性达87 .3 % ,而76 .09 % 的良性肺病患者三项指标均为阴性。结论:对影像学可疑肺部肿瘤的患者进行支气管肺胞灌洗检测 C E A、β2 - M G 以及瘤细胞学等三项联合,对诊断与鉴别诊断支气管肺癌有重要参考价值,尤其对周围型肺癌,纤维支气管镜检查肉眼无明显病变而临床可疑者更具重要价值。 Objective:To study the diagnostic value of the combined tumer markers in bronchoalveolar lavage fluids(BALFs) to lung cancer.Method:Flexible fiberoptic bronchoscopy was adopted and the BALFs were collected.Carcinoembryonic antigent (CEA)and β 2 -Microgobulin( β 2 -MG) in the BALFs were measured and statistically analyzed after being adjusted by potassium ion (K +).Results:CEA/K +and β 2 -MG/K +in the BALFs from the lung cancer group were significantly higher than those of the BALFs from the benign pneumopathy group with a great significant postive ratio.If CEA/K +and cancerous cells were jointly tested,93 75%cancerous patients were positive to at least one or more index of these three tests .The ratio of accurate diagnosis was 87.32%.On the other hand,the three tests in 76.09%patients of the benign pneumopathy were negative.Conclusions:The combined measurement of CEA, β 2 -MG and cancerous cells in BALFs has a very important value in the diagnosis of lung cancer for the patients being suspected by iconography,especially for the periphery lung cancer and the suspectable patients without any lesion under macroscopy,who were suspected by clinical manifestation
出处 《中国内镜杂志》 CSCD 1999年第4期3-5,共3页 China Journal of Endoscopy
关键词 支气管肺泡 灌洗液 肿瘤标志物 肺癌 诊断 Bronchoalveolar Lavage Fluids Tumor marker Lung cancer
  • 相关文献

参考文献2

二级参考文献4

  • 1孙德本,实用内科杂志,1987年,7期,230页
  • 2董陆佳,实用内科杂志,1986年,6期,208页
  • 3邓家栋,临床血液学,1985年
  • 4浦权,实用血液病学,1985年

共引文献3

同被引文献55

  • 1武玉欣.肿瘤标志物的种类及实用性[J].日本医学介绍,2005,26(2). 被引量:2
  • 2廖秋林,陈铭声.肺癌患者血清肿瘤活性标志物的检测及其临床意义[J].中国实用内科杂志,2005,25(6):514-515. 被引量:17
  • 3郑有为,梁敏文,陈达强.肺癌患者的血清和支气管肺泡灌洗液中的组织多肽特异性抗原的测定[J].陕西医学检验,1996,11(3):13-14. 被引量:6
  • 4罗素霞 陈小兵 肖毅军 等.支气管肺泡灌洗液中3种肿瘤标志物检测的临床价值.癌症进展,2005,21(03):73-77.
  • 5Bonner JA, Sloan JA, Rowland KM Jr, et al. Significance of neuronspecific enolase levels before and during therapy for small cell lung cancer [ J ]. Clin Cancer Res,2000,6 (2) :597-601.
  • 6Pujol JL, Boher JM, Grenier J, et al. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients [ J ]. Lung Cancer,2001,31 ( 2 -3 ) : 221-231.
  • 7Plebani M, Basso D, Navaglia F,et al. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results[ J]. Br J Cancer, 1995,72( 1 ) :170-173.
  • 8Schneider J, Velcovsky HG, Morr H, et al. Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer [ J ]. Anticancer Res, 2000,20 ( 6D ) : 5053- 5058.
  • 9Miyake Y, Kodama T, Yamaguchi K, et al. Pro-gastrin-releasing peptide( 31-98 ) is a specific tumor marker in patients with small cell lung carcinoma [ J ]. Cancer Res, 1994,54 ( 8 ) :2136-2140.
  • 10姚连昌.肺癌的生物标记[M].北京:中国协和医科大学出版社,2000.791.

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部